Quick Answer
CervoMed Inc. reported Diluted EPS of $2038891.00 per share for fiscal year 2022.
CervoMed Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2022 | $2038891.00 | +4.7% |
| 2021 | $1946859.00 | -96.4% |
| 2020 | $53831973.00 | +702.7% |
| 2019 | $6706509.00 | +106.8% |
| 2018 | $3242301.00 | +11138200.3% |
| 2017 | -$29.11 | -1554.0% |
| 2016 | -$1.76 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2024 | -$0.55 | +21.4% | +21.4% |
| September 30, 2023 | -$0.70 | +58.8% | +58.8% |
| September 30, 2022 | -$1.70 | -100.0% | -100.0% |
| September 30, 2021 | $101903979.00 | +59.2% | +0.0% |
| June 30, 2021 | $101903979.00 | +96.1% | +22.2% |
| March 31, 2021 | $83420184.00 | +141.7% | +30.3% |
| September 30, 2020 | $64011342.00 | +1263.9% | +23.2% |
| June 30, 2020 | $51978286.00 | +1219.0% | +50.6% |
- CervoMed Inc. showed an increase of +4.7% in Diluted EPS compared to the prior fiscal year.
- Over the 2016–2022 period, CervoMed Inc.’s diluted eps has grown by 115846179.5% (from $1.76 per share (loss) to $2038891.00 per share).
- The most recent figure is from CervoMed Inc.’s fiscal year 2022 report (Form 10-K), filed with the SEC on March 24, 2023.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: